CanadaBuys #20183030

Santé Québec seeks an Oxford Nanopore PromethION P2 Integrated sequencing instrument

Santé Québec plans to acquire a real-time sequencing instrument for CHU de Québec - Université Laval through a proposed sole-source purchase. - Government buyer: Santé Québec, specifically CHU de Québec - Université Laval. - OEM and vendor: Oxford Nanopore Technologies Canada Limited, manufacturer and proposed supplier of the Oxford Nanopore PromethION P2 Integrated. - Product requested: One PromethION P2 Integrated real-time nucleic acid sequencing instrument; quantity and part number are not specified. - Must sequence DNA fragments from 50 to over 100,000 nucleotides, with 50–100 billion sequenced nucleotides per flow cell and two independent reading flow cells. - Must support reusable flow cells, real-time base calling, onboard computing, adaptive sampling, and multiplexing of at least 96 samples per flow cell. - Must directly sequence full-length native RNA and detect specified DNA modifications without pretreatment. - Must include more than 10 TB of internal storage and work with compatible commercial library-preparation kits. - Must meet stated footprint, standard 110–120V power, CSA approval, and cleaning/disinfection compatibility requirements. - Service requested: Complete technical support for all sequencing workflows on business days; quantity and part number are not specified. - Notable procurement context: The buyer identifies the PromethION P2 Integrated as the only benchtop instrument found to meet its scientific requirements. A prior tender received no bids; a legally admissible expression of interest from a qualified supplier could lead the buyer to abandon the proposed sole-source purchase and issue a public tender. - Period: Estimated contract duration is 48 months; no specific start or end dates or annual subscription terms are provided.

Description

Santé Québec - CHU de Québec - Université Laval intends to award a sole-source contract to Oxford Nanopore Technologies Canada Limited for a real-time nucleic acid sequencing instrument. The instrument must support long-read DNA and native RNA sequencing, real-time base calling and adaptive sampling, detection of DNA modifications, and the specified throughput, storage, power, and physical requirements. The notice states that the PromethION P2 Integrated is the only benchtop instrument identified as meeting all stated scientific requirements. Expressions of interest are due electronically by November 22, 2026; a qualified, legally admissible response may lead the organization to cancel the sole-source award intention and issue a public tender.

View original listing